Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Castration-resistant Prostate Cancer 1 Castration-Resistant Prostate Carcinoma 1 Castration Resistant Metastatic Prostate Cancer 1

Interventions

enzalutamide 92 Magnetic Resonance Spectroscopy 87 Specimen Handling 66 Prednisone 65 Androgen Antagonists 59 Abiraterone Acetate 59 apalutamide 56 Radiosurgery 53 Radiotherapy 47 Leuprolide 47 darolutamide 46 abiraterone 44 Docetaxel 43 Radiation 31 Pluvicto 31 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 30 Biopsy 30 relugolix 28 Surveys and Questionnaires 28 pembrolizumab 26 gallium 68 PSMA-11 26 Standard of Care 26 Triptorelin Pamoate 25 Goserelin 25 bicalutamide 23 Gonadotropin-Releasing Hormone 23 Brachytherapy 21 Carboplatin 20 X-Rays 19 luprolide acetate gel depot 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms × testosterone enanthate × 1 year × Clear all

NCT06594926 2026-04-24

WOMBAT

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

Phase 2 Recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡